Human Retroviral Infections Immunological and Therapeutic Control /
The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquire...
Corporate Author: | |
---|---|
Other Authors: | , , |
Format: | Electronic |
Language: | English |
Published: |
Boston, MA :
Springer US,
2002.
|
Series: | Infectious Agents and Pathogenesis,
|
Subjects: | |
Online Access: | View fulltext via EzAccess |
Table of Contents:
- The Two Principal Viremias of HIV
- Potential Role of Human T-cell Leukemia/Lymphoma Viruses (HTLV) in Diseases Other Than Acute T-cell Leukemia/Lymphoma (ATL)
- Viral-Related Proteins in Immune Dysfunction Associated with AIDS
- Carbohydrate Interactions and HIV-1
- HTLV-I and HTLV-II Infection
- Vaccine Approaches for Human T-cell Lymphotropic Virus Type I
- Immune Responses againstHIV-2
- HIV Mucosal Vaccines
- Nucleic Acid Vaccination against HIV-1
- Passive Immunotherapy against HIV-1
- Human Immunodeficiency Virus Type 1 Accessory Genes
- A New Generation of Antiviral Therapeutics Designed to Prevent the Use of Chemokine Receptors for Entry by HIV-1
- Protease Inhibitors and HIV-1 Genetic Variability in Infected Children
- Gene Therapy and HIV-1 Infection
- Pediatric HIV.